In the hypertension study, UCSD will obtain DNA from a group of patients, then send it to TCAG for sequencing and SNP analysis. While TCAG conducts the sequencing, UCSD researchers will simultaneously run phenotyping tests.
UCSD actually began the hypertension study two years ago with a $2.9 million, four-year grant from the National Heart, Lung and Blood Institute as part of the NIH Pharmacogenomics network. Preliminary results will be announced next month at the Society for Human Genetics meeting in
UCSD's agreement with TCAG is detailed in a multi-year Memorandum of Understanding